Fenofibrate is a lipid-lowering agent primarily prescribed to reduce cholesterol and triglyceride levels in patients at risk of cardiovascular disease. Commonly marketed under various brand names, Fenofibrate works by activating peroxisome proliferator-activated receptors (PPARs), which enhance the breakdown of lipids in the blood. Maintaining the pharmaceutical purity of Fenofibrate is essential to ensure therapeutic effectiveness, minimize adverse effects, and meet regulatory standards. Impurity profiling is crucial for identifying and controlling unwanted substances that may form during manufacturing, storage, or degradation. Here are some of its known impurities listed below.
Showing 1 - 1 of 1 products
